uniQure upgraded at Mizuho on improved outlook for Huntington's asset AMT-130
Source: SeekingAlpha
2026-03-12 18:31:34 ET
More on uniQure
- A Unique Situation For UniQure
- uniQure: Worst Case Scenario Becomes Reality
- uniQure: The Worst Case Scenario Just Got Official (Rating Downgrade)
- Biotech firm stocks rise on FDA vaccine head’s exit
- uniQure surges following departure of key FDA official
Read the full article on Seeking Alpha
For further details see:
uniQure upgraded at Mizuho on improved outlook for Huntington's asset AMT-130
uniQure N.V.
NASDAQ: QURE
QURE Trading
18.55% G/L:
$20.035 Last:
2,309,692 Volume:
$17.97 Open:
QURE Latest News
April 30, 2026 07:05:00 am
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington's Disease
QURE Stock Data
$1,555,111,367
59,307,892
N/A
61
N/A
Biotechnology & Life Sciences
Healthcare
NL
Amsterdam
